Subject ID | Group | Ethnicity | Gender | Birth Mode | Gestational Term | a Antibiotics intake prior to diagnosis | b Risk Group | Chemotherapy duration (months) | Follow-up Duration (months) |
---|---|---|---|---|---|---|---|---|---|
AL3 | Patient | Malay | Female | Vaginal | Term | Yes | Intermediate | 27 | 34 |
AL4 | Patient | Malay | Male | NA | Term | Yes | Standard | 25 | 34 |
AL8 | Patient | Malay | Male | Vaginal | Term | Yes | Standard | 25 | 29 |
AL10 | Patient | Malay | Male | Vaginal | Term | Yes | Intermediate | 27 | 31 |
AL13 | Patient | Malay | Male | Vaginal | Term | Yes | Standard | 25 | 30 |
AL15 | Patient | Malay | Male | Vaginal | Term | Yes | Intermediate | 26 | 31 |
AL18 | Patient | Malay | Male | Vaginal | Post-term | Yes | Standard | 24 | 29 |
a Antibiotics intake prior to sampling | |||||||||
IM18C | Control | Malay | Male | Vaginal | Term | No | – | – | – |
ConC1 | Control | Malay | Male | Vaginal | Term | No | – | – | – |
ConC2 | Control | Malay | Male | Vaginal | Term | No | – | – | – |
ConC4 | Control | Malay | Female | Vaginal | Term | No | – | – | – |
ConC5 | Control | Malay | Male | Vaginal | Term | No | – | – | – |
ConCP3 | Control | Malay | Male | Vaginal | Term | No | – | – | – |
ConCP5 | Control | Malay | Male | Vaginal | Term | No | – | – | – |